technetium tc 99m pentetate has been researched along with fumarates in 1 studies
| Studies (technetium tc 99m pentetate) | Trials (technetium tc 99m pentetate) | Recent Studies (post-2010) (technetium tc 99m pentetate) | Studies (fumarates) | Trials (fumarates) | Recent Studies (post-2010) (fumarates) |
|---|---|---|---|---|---|
| 3,336 | 275 | 394 | 4,655 | 342 | 1,823 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camerotto, A; Fiorini, F; Maffione, AM; Marzola, MC; Mazza, A; Montemurro, D; Rampin, L; Rubello, D; Schiavon, L; Vescovo, G; Zuin, M | 1 |
1 other study(ies) available for technetium tc 99m pentetate and fumarates
| Article | Year |
|---|---|
(99m)Tc-DTPA scintigraphy assesses the absence of glomerular filtration rate impairment of Aliskiren in high-risk hypertensive subjects. A 12-month follow-up study.
Topics: Adult; Aged; Amides; Antihypertensive Agents; Blood Pressure; Female; Follow-Up Studies; Fumarates; Glomerular Filtration Rate; Humans; Hypertension; Male; Middle Aged; Radiopharmaceuticals; Sex Factors; Technetium Tc 99m Pentetate; Time Factors | 2014 |